Profile data is unavailable for this security.
About the company
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by-side, healing by supporting the surrounding tissue after injury, minimizing the expansion of areas of necrosis, and providing a biomaterial substrate for the body's own healing/repair processes following injury. It is composed of two biocompatible and bioresorbable polymers that are cast to form a porous investigational product: Poly lactic-co-glycolic acid and Poly-L-Lysine. Poly lactic-co-glycolic acid is a polymer that is used in resorbable sutures and provides biocompatible support for Neuro-Spinal Scaffold implants and Poly-L-Lysine is a positively charged polymer used to coat surfaces.
- Revenue in USD (TTM)0.00
- Net income in USD-9.33m
- Incorporated2003
- Employees6.00
- LocationInVivo Therapeutics Holdings CorpBuilding 1400 East 4Th FloorOne Kendall SquareCAMBRIDGE 02139United StatesUSA
- Phone+1 (617) 863-5524
- Websitehttps://www.invivotherapeutics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SETO Holdings Inc | 4.96m | -652.00k | 1.00m | 18.00 | -- | 0.0911 | -- | 0.2024 | -0.056 | -0.056 | 0.3994 | 0.134 | 1.57 | 2.65 | 8.51 | -- | -20.70 | 3.84 | -29.07 | 5.95 | 52.83 | 52.44 | -13.15 | 3.92 | 0.9921 | 1.24 | 0.304 | 0.00 | 19.01 | 5.44 | -61.23 | -- | -- | -- |
| Motus GI Holdings Inc | 327.00k | -16.10m | 1.04m | 15.00 | -- | 0.3058 | -- | 3.18 | -12.68 | -12.68 | 0.1134 | 0.5886 | 0.0339 | 1.18 | 4.92 | 21,800.00 | -109.80 | -80.63 | -182.50 | -112.32 | -24.46 | -44.53 | -3,239.76 | -6,160.58 | 1.67 | -13.01 | 0.4287 | -- | -46.11 | 54.70 | 30.81 | -- | -28.25 | -- |
| Remedent Inc | 1.13m | -259.38k | 1.10m | 16.00 | -- | 0.2324 | -- | 0.9743 | -0.013 | -0.013 | 0.0565 | 0.2367 | 0.1474 | 3.45 | 2.69 | -- | -3.24 | 7.35 | -5.20 | 12.93 | 65.38 | 64.60 | -21.97 | 21.20 | 0.2033 | -0.772 | 0.00 | -- | -33.63 | -21.70 | -140.31 | -- | -- | -- |
| Grapefruit USA Inc | 34.85k | -4.37m | 1.11m | 9.00 | -- | -- | -- | 31.76 | -0.008 | -0.008 | 0.00006 | -0.0101 | 0.0121 | 1.31 | 0.2259 | 3,872.22 | -151.85 | -268.93 | -- | -- | -1,304.65 | -10.09 | -12,531.68 | -408.87 | 0.0388 | -1.50 | -- | -- | -83.96 | 77.87 | -35.68 | -- | -- | -- |
| SPO Global Inc | 838.00k | -540.00k | 1.17m | 2.00 | -- | -- | -- | 1.39 | -85.99 | -85.99 | 131.76 | -476.56 | 1.76 | -- | -- | -- | -113.56 | -305.39 | -- | -- | 31.15 | 27.31 | -64.44 | -384.85 | -- | -1.45 | -- | -- | -17.09 | -15.13 | 13.03 | -- | -- | -- |
| Invivo Therapeutics Holdings Corp | 0.00 | -9.33m | 1.24m | 6.00 | -- | 0.1387 | -- | -- | -3.53 | -3.53 | 0.00 | 2.87 | 0.00 | -- | -- | 0.00 | -81.32 | -73.69 | -94.35 | -85.63 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -6.01 | -- | 19.74 | -- |
| Escalon Medical Corp | 11.65m | -296.71k | 1.30m | 38.00 | -- | 1.26 | -- | 0.1114 | -0.0401 | -0.0401 | 1.29 | 0.2259 | 2.40 | 3.75 | 7.51 | 306,456.30 | -1.26 | -1.76 | -2.84 | -3.67 | 44.07 | 44.57 | -0.5265 | -0.9114 | 0.8927 | -1.62 | 0.1584 | -- | 13.80 | 1.33 | 760.89 | -17.06 | -19.85 | -- |
| Acutus Medical Inc | 9.55m | -9.70m | 1.32m | 233.00 | -- | -- | -- | 0.1382 | -0.3301 | 0.0956 | 0.3261 | -0.1353 | 0.1211 | 1.14 | 1.46 | 40,974.25 | -12.30 | -46.76 | -14.84 | -56.88 | -24.07 | -89.12 | -101.56 | -773.49 | 2.89 | -4.64 | 1.13 | -- | 136.36 | 27.03 | -141.35 | -- | -35.99 | -- |
| Nemaura Medical Inc | 0.00 | -10.65m | 1.40m | 36.00 | -- | -- | -- | -- | -0.3787 | -0.3787 | 0.00 | -0.6169 | 0.00 | 0.00 | -- | 0.00 | -117.49 | -58.18 | -- | -131.96 | -- | -- | -- | -7,384.83 | 0.0305 | -1.47 | 10.81 | -- | -84.71 | -- | -1.85 | -- | 64.14 | -- |
| Kelyniam Global Inc | 517.70k | -420.28k | 1.80m | 0.00 | -- | 3.36 | -- | 3.48 | -0.0253 | -0.0253 | 0.0312 | 0.0179 | 0.4135 | 7.04 | 4.38 | -- | -33.57 | -- | -41.79 | -- | 18.86 | -- | -81.18 | -- | 1.26 | -- | 0.6232 | -- | -26.47 | -- | -19.10 | -- | -- | -- |
| Bone Biologics Corp | 0.00 | -6.10m | 1.83m | 2.00 | -- | 0.4592 | -- | -- | -23.10 | -23.10 | 0.00 | 3.62 | 0.00 | -- | -- | 0.00 | -114.93 | -98.31 | -189.37 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -502.76 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 31 Dec 2023 | 163.10k | 5.25% |
| VIMA LLCas of 31 Mar 2024 | 2.00 | 0.00% |
| Barclays Capital, Inc.as of 31 Mar 2024 | 2.00 | 0.00% |
| Sugarloaf Wealth Management LLCas of 31 Mar 2024 | 1.00 | 0.00% |
| Allworth Financial LPas of 31 Mar 2024 | 0.00 | 0.00% |
| Tower Research Capital LLCas of 31 Mar 2024 | 0.00 | 0.00% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Mar 2024 | 0.00 | 0.00% |
| Indiana Trust & Investment Management Co.as of 31 Mar 2024 | 0.00 | 0.00% |
| UBS Financial Services, Inc.as of 31 Mar 2024 | 0.00 | 0.00% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 0.00 | 0.00% |
